Rotavirus vaccines (RV) are safe and effective but demand significant investment of healthcare 13 resource. In countries with low mortality due to rotavirus, a key component to assessing cost-14 effectiveness is quantifying the Health Related Quality of Life (HRQoL) lost due to rotavirus acute 15 gastroenteritis (RVAGE). 16
Introduction 35
Rotavirus is the commonest cause of gastroenteritis in childhood and most children will have 36 suffered from it at least once by the time they are five years old. [1] Although prevalent in all 37 countries, the burden of rotavirus is far from equitable. In developing countries with limited access 38 to healthcare, it is estimated to lead to the deaths of half a million children under the age of five per 39 year. Cost effectiveness is often summarised by the incremental cost effectiveness ratio (ICER) which 53 represents the cost implications per net change in QALYs. In the UK, NICE suggests that an ICER less 54 than £20-30,000 per QALY is likely to be cost-effective. To fully capture the benefits of an 55 intervention, NICE recommends that all direct health benefits (not just those for the patient) should 56 be taken into account. Reviews have found that this is still a relatively uncommon practice, most 57 often applied in health economic assessments of chronic diseases with informal but long term caring 58 commitments such as dementia. [6-8] 59
Although there have been many assessments of the clinical burden[9-11] and secondary economic 60 costs to families, [12, 13] loss of parents and children to be a major determining factor of vaccine cost effectiveness. As the 64 severity of cases seen in primary care may not be representative of the whole spectrum of rotavirus 65 disease, we sought to determine the effects of more severe rotavirus infection on the HRQoL of a 66 cohort of children and their parents in the UK to help provide additional data to parameterise any 67 future cost effectiveness analyses. 68
Methods 69
Children presenting with symptoms of gastroenteritis (>2 loose stools and/or >1 episode of forceful 70 vomiting in the last 24 hours) under six years of age were recruited from the paediatric emergency 71 department of Bristol Royal Hospital for Children. After obtaining informed consent, a short 72 questionnaire assessed childrens' and their carers' quality of life at the point of presentation to 73 hospital and asked for how long symptoms had been present. The impact of the child's illness on 74 the quality of life of the primary, and when present, secondary carer was assessed using the EQ5D-75 5L[18] using UK 3L-5L crosswalk valuation sets for valuation [19] . Children's HRQoL was assessed 76 using the Health Utilities Index 2 (HUI2) [20] questionnaire with the addition of the EQ5D visual 77 analogue scale (VAS) which is anchored at 0 -"best health you can imagine" to 100-"worst health 78 you can imagine". Clinical severity was assessed using the Vesikari [21] scoring system. This scale 79 was developed for the assessment of rotavirus vaccines and combines the length and frequency of 80 symptoms, degree of dehydration and level of treatment required to assign a score between 0 and 81 20. In its derivation community cohort of children with rotavirus gastroenteritis the mean score was 82 11 (standard deviation 3.7); conventionally severe gastroenteritis is defined as a score greater than 83 10. A stool sample was collected and tested for viral causes of gastroenteritis using routine clinical 84 PCR. Families were asked to complete a daily diary card recording children's symptoms, days of 85 missed work, childcare and healthcare use until they felt their child had returned to normal health 86 (see appendix 1 for example page). At this point there was a final assessment of the whole family's 87
HRQoL and the diary was returned by post. 88 
QALY loss due to rotavirus gastroenteritis. 92
As rotavirus is usually a transient self limiting illness with no long term effects, we assumed that a 93 child's pre-morbid HRQoL would be the same as their HRQoL once they had recovered from the 94 acute illness. To calculate HRQoL loss we estimated a constant linear decrease from the pre-morbid 95 baseline at reported symptom start to a nadir at point of presentation to the emergency department 96 and then constant improvement to return to baseline by the reported end date. (Figure 1 ) 97
Any incomplete domains were scored as perfect health. Non parametric distributions were 98 compared using the Mann -Whitney U test. Confidence intervals for the mean were derived from 99 1000 bootstrap iterations. Statistical analyses were performed using R.
[22] 100
The study was approved by the South West Central Bristol NRES ethics committee (REC12/SW/0359) 101 and funded through a University Hospitals Bristol NHS Foundation Trust Clinical PhD studentship. 102
Results

103
129 families consented to take part in the study, 118 (91%) completed the initial questionnaire and 104 59 (46%) returned the diary. Of the 84 (65%) found to be rotavirus positive, 77 completed the initial 105 questionnaire and 48 returned the diary. Childrens' median age was 14 months (IQR 10-22m) and 106 52% were male. Children had been ill for a mean 4 (95%CI 3.5-4.6) / median 4 (IQR 2-5) days before 107 attending the emergency department. 41 (53%) children required hospital admission. The mean 108
Vesikari score on attendance was 11.2 (SD 2.5 range 5-18) with 66% categorised as severe ( Table 1 shows the mean HRQoL of children and carers at presentation and at final assessment in 112 those who returned diaries. At time of presentation to the emergency department, the main 113 domains reported to be affected in children were emotion and pain, with 81% and 64% reporting 114 reduced scores, respectively. In adults the main domains were usual activities and anxiety (with 64% 115 and 62% of cases reporting reduced scores, respectively). There were no significant differences in 116 reported initial HRQoL (p=0.72), disease severity (p=0.92), rate of admission (p=0.23) or length of 117 illness prior to attendance (p=0.5) between those who did and did not return the diaries. Children 118 whose parents returned the diaries tended to be slightly older (median 15.8 vs 11.1 months (p=0.06) 119 than those who did not, but were not significantly different (p=0.2) from the total age distribution of 120 gastroenteritis attendances to the Emergency Department. Families reported their children to 121 remain ill for a mean 5.7 (95%CI 5.1-6.5) / median of 5.5 (IQR 4-7) additional days following initial 122 interview. 123
Parents were asked to self allocate as the primary (n=48) or secondary (n=41) carer. In all but one 124 case (where there was a single father), the mother was recorded as primary carer. There were five 125 single mothers families leaving 40 fathers and one grandmother recorded as secondary carers. 126
Within the completed diary cohort, at least one other member developed a secondary case of 127 gastroenteritis in 52% of households. For working carers, 69% missed a mean 2.8 (95% CI 2.3-3.4), 128 median 2.3 (IQR 1.4 -3.8) days of work. 129
For our primary analysis, in those who returned their diaries, we calculated QALY loss using the last 130 reported HRQoL as baseline, i.e. we assumed that by the end of the study individuals had returned 131 to normal health. For children this equated to a mean loss of 3.
gender. This resulted in a higher estimated QALY loss for children and the primary carer, although 140 confidence intervals overlapped with our primary estimates. 141 142 Between countries, different attitudes to health seeking behaviour and accessibility to health 177 services will dictate the severity of cases seen in a particular healthcare setting. In the UK, with the 178 re-organisation of primary care provision, increasing numbers of families now present directly to 179 the Emergency Department for minor medical illnesses.
[27] Thus paediatric emergency 180 departments have a very varied case mix, providing both primary care to self-referrals as well as 181 secondary assessments of more severe cases. Within our cohort only 12% had been referred to 182 hospital by their GP, yet 60% reported that they had already consulted their GP at least once during 183 the episode. Despite 53% requiring admission, our cohort's mean HRQoL was significantly higher 184 than Thai inpatients (p<0.001), and most similar to those reported from Danish primary care. Both 185 our HRQoL (p<0.001) and sensitivity QALY loss (p<0.001) estimates are significantly greater than 186 those measured by Brisson et al [17] . Although underpowered, our subgroup analysis suggests that 187 even patients that could be discharged from the emergency department have a greater QALY loss 188 than in Canadian primary care; with those requiring admission reporting a trend towards greater 189
effects. 190
The main limitation of our study is that in an effort to reduce the burden on families already looking 191 after sick children, rather than require daily diary entry for a fixed period, we allowed carers to 192 report when they considered their child to be recovered and return the diary at that point. With an increasing number of vaccines being developed but finite healthcare resources, the decision 220 of which ones to introduce can become problematic. For well informed recommendations using our 221 current cost per QALY approach; it is essential that there are accurate data characterising the burden 222 of common childhood illness being collected. Our results suggest that RV gastroenteritis has a significantly higher impact on the quality of life of 227 children and their carers in the UK than previously reported in studies done elsewhere. The results 228 of the first year of vaccination in the UK appear to show a large reduction in rates of disease [39] . 229
Our findings imply the programme will have been more cost effective than previously estimated, 230
since the QALY losses we show in children presenting to the Emergency Department and their 231 families are higher than the estimates used in the cost effectiveness studies which drove the 232 recommendation to introduce the vaccine. These figures may be of value to other European 233 countries still evaluating the cost-effectiveness of introducing rotavirus vaccination. 234 
